The role of the IL23/IL17 pathway in inflammatory bowel disease

The role of the IL23/IL17 pathway in inflammatory bowel disease

<p>The aetiology of IBD is unknown, but available evidence suggests that an aberrant immune response towards the commensal microbial flora is responsible for intestinal inflammation in genetically susceptible individuals. Studies from animal models of intestinal inflammation have greatly advan...

Descrizione completa

Dettagli Bibliografici
Autore principale:	Geremia, A
Altri autori:	Powrie, F
Natura:	Tesi
Lingua:	English
Pubblicazione:	2011
Soggetti:	Gastroenterology Immunology Medical Sciences

Documenti analoghi

The role of IL-1beta in intestinal inflammation
di: Coccia, M, et al.
Pubblicazione: (2011)

Studies of intestinal inflammation: the roles of IL-23R, gamma-delta T-cells and IL-21i
di: Shale, M
Pubblicazione: (2013)

The role of IL-18 in intestinal immune regulation
di: Harrison, O, et al.
Pubblicazione: (2013)

The role of IL-18 in intestinal immune regulation
di: Harrison, OJ
Pubblicazione: (2013)

Investigation of the signalling and function of NOD2
di: Brain, A
Pubblicazione: (2013)

Genetic studies in ulcerative colitis
di: Bryant, RV
Pubblicazione: (2015)

Medication adherence and complementary therapy usage in inflammatory bowel disease patients during the coronavirus disease 2019 pandemic
di: Alex Barnes, et al.
Pubblicazione: (2021-05-01)

Selective IgA2 deficiency in a patient with small intestinal Crohn’s disease
di: Pablo Canales-Herrerias, et al.
Pubblicazione: (2023-06-01)

The function of NOD2 in antigen presenting cells
di: Allan, P
Pubblicazione: (2012)

Assessing effectiveness and patient perceptions of a novel electronic medical record for the management of inflammatory bowel disease
di: Patricia Kaazan, et al.
Pubblicazione: (2021-09-01)

Innate immune pathways controlling IL-1beta production and adjuvant-induced T helper 17 cell differentiation
di: Shenderov, K
Pubblicazione: (2011)

Implications of HCV genotype 3 specific immunity on cross-reactive vaccine design
di: von Delft, A, et al.
Pubblicazione: (2014)

Microbial signals, MyD88, and lymphotoxin drive TNF-independent intestinal epithelial tissue damage
di: Iulia Rusu, et al.
Pubblicazione: (2022-03-01)

The minichromosome maintenance complex drives esophageal basal zone hyperplasia
di: Mark Rochman, et al.
Pubblicazione: (2023-09-01)

Cystathionine γ-lyase exacerbates Helicobacter pylori immunopathogenesis by promoting macrophage metabolic remodeling and activation
di: Yvonne L. Latour, et al.
Pubblicazione: (2022-06-01)

Intestinal epithelial HDAC3 and MHC class II coordinate microbiota-specific immunity
di: Emily M. Eshleman, et al.
Pubblicazione: (2023-02-01)

TSLP/dendritic cell axis promotes CD4+ T cell tolerance to the gut microbiome
di: Jonathan L. Messerschmidt, et al.
Pubblicazione: (2023-07-01)

AI-assisted discovery of an ethnicity-influenced driver of cell transformation in esophageal and gastroesophageal junction adenocarcinomas
di: Pradipta Ghosh, et al.
Pubblicazione: (2022-09-01)

SMAD4 TGF-β–independent function preconditions naive CD8+ T cells to prevent severe chronic intestinal inflammation
di: Ramdane Igalouzene, et al.
Pubblicazione: (2022-04-01)

Use of genome wide expression profiles in analysis of T cell dysfunction in Hepatitis C virus infection
di: Gupta, P
Pubblicazione: (2014)

Investigating checkpoint inhibitor-induced gastrointestinal disease: comparisons with idiopathic ulcerative colitis and health
di: Gupta, T
Pubblicazione: (2022)

Function, phenotype and development of human CD161+CD8 T cells
di: Walker, LJ
Pubblicazione: (2012)

Single cell atlas of human gastric muscle immune cells and macrophage-driven changes in idiopathic gastroparesis
di: Lakshmikanth L. Chikkamenahalli, et al.
Pubblicazione: (2024-03-01)

Gut-microbiota-based ensemble model predicts prognosis of pediatric inflammatory bowel disease
di: Sung Min Ha, et al.
Pubblicazione: (2024-12-01)

Prolonged dysbiosis and altered immunity under nutritional intervention in a physiological mouse model of severe acute malnutrition
di: Fanny Hidalgo-Villeda, et al.
Pubblicazione: (2023-06-01)

Forward genetic and cellular studies of immune regulation: the roles of Carma1, Interleukin-10 and Gimap5
di: Barnes, MJ
Pubblicazione: (2010)

Role of the IL23/IL17 Pathway in Crohn’s Disease
di: Heike Schmitt, et al.
Pubblicazione: (2021-03-01)

Contrast‐enhanced ultrasonography in dogs with inflammatory bowel disease
di: Nikolina Linta, et al.
Pubblicazione: (2021-09-01)

Achieving Treatment Goals in Inflammatory Bowel Disease: The Role of Gut-Selective Therapy
di: Gert Van Assche, et al.
Pubblicazione: (2015-12-01)

Novel Pharmacological Approaches for Inflammatory Bowel Disease: Targeting Key Intracellular Pathways and the IL-23/IL-17 Axis
di: Leo R. Fitzpatrick
Pubblicazione: (2012-01-01)

IL-23 tunes inflammatory functions of human mucosal-associated invariant T cells
di: Laetitia Camard, et al.
Pubblicazione: (2025-02-01)

Pirfenidone increases IL-10 and improves acute pancreatitis in multiple clinically relevant murine models
di: Ejas Palathingal Bava, et al.
Pubblicazione: (2022-01-01)

Bacterially Derived Tryptamine Increases Mucus Release by Activating a Host Receptor in a Mouse Model of Inflammatory Bowel Disease
di: Yogesh Bhattarai, et al.
Pubblicazione: (2020-12-01)

Stem cell and niche regulation in human short bowel syndrome
di: Vered A. Gazit, et al.
Pubblicazione: (2020-12-01)

Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
di: Claudia Schinocca, et al.
Pubblicazione: (2021-02-01)

Connective tissue changes in patients with rectal prolapse
di: Smyth, EAE
Pubblicazione: (2012)

Identification of the cellular and molecular mechanisms of IL-23 driven intestinal inflammation
di: Schiering, C
Pubblicazione: (2013)

IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease.
di: Geremia, A, et al.
Pubblicazione: (2011)

The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
di: Taoming Liu, et al.
Pubblicazione: (2020-11-01)

Osteopontin regulation of MerTK+ macrophages promotes Crohn’s disease intestinal fibrosis
di: Juanhan Liu, et al.
Pubblicazione: (2024-07-01)